126 related articles for article (PubMed ID: 20380812)
1. Photodynamic therapy targeting neuropilin-1: Interest of pseudopeptides with improved stability properties.
Thomas N; Pernot M; Vanderesse R; Becuwe P; Kamarulzaman E; Da Silva D; François A; Frochot C; Guillemin F; Barberi-Heyob M
Biochem Pharmacol; 2010 Jul; 80(2):226-35. PubMed ID: 20380812
[TBL] [Abstract][Full Text] [Related]
2. Peptide-conjugated chlorin-type photosensitizer binds neuropilin-1 in vitro and in vivo.
Thomas N; Bechet D; Becuwe P; Tirand L; Vanderesse R; Frochot C; Guillemin F; Barberi-Heyob M
J Photochem Photobiol B; 2009 Aug; 96(2):101-8. PubMed ID: 19464192
[TBL] [Abstract][Full Text] [Related]
3. Metabolic profile of a peptide-conjugated chlorin-type photosensitizer targeting neuropilin-1: an in vivo and in vitro study.
Tirand L; Thomas N; Dodeller M; Dumas D; Frochot C; Maunit B; Guillemin F; Barberi-Heyob M
Drug Metab Dispos; 2007 May; 35(5):806-13. PubMed ID: 17283031
[TBL] [Abstract][Full Text] [Related]
4. A peptide competing with VEGF165 binding on neuropilin-1 mediates targeting of a chlorin-type photosensitizer and potentiates its photodynamic activity in human endothelial cells.
Tirand L; Frochot C; Vanderesse R; Thomas N; Trinquet E; Pinel S; Viriot ML; Guillemin F; Barberi-Heyob M
J Control Release; 2006 Mar; 111(1-2):153-64. PubMed ID: 16423422
[TBL] [Abstract][Full Text] [Related]
5. Tissue distribution and pharmacokinetics of an ATWLPPR-conjugated chlorin-type photosensitizer targeting neuropilin-1 in glioma-bearing nude mice.
Thomas N; Tirand L; Chatelut E; Plénat F; Frochot C; Dodeller M; Guillemin F; Barberi-Heyob M
Photochem Photobiol Sci; 2008 Apr; 7(4):433-41. PubMed ID: 18385885
[TBL] [Abstract][Full Text] [Related]
6. Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1.
Starzec A; Vassy R; Martin A; Lecouvey M; Di Benedetto M; Crépin M; Perret GY
Life Sci; 2006 Nov; 79(25):2370-81. PubMed ID: 16959272
[TBL] [Abstract][Full Text] [Related]
7. New Peptide-Conjugated Chlorin-Type Photosensitizer Targeting Neuropilin-1 for Anti-Vascular Targeted Photodynamic Therapy.
Kamarulzaman EE; Gazzali AM; Acherar S; Frochot C; Barberi-Heyob M; Boura C; Chaimbault P; Sibille E; Wahab HA; Vanderesse R
Int J Mol Sci; 2015 Oct; 16(10):24059-80. PubMed ID: 26473840
[TBL] [Abstract][Full Text] [Related]
8. A study of the stability of tri(glucosyloxyphenyl)chlorin, a sensitizer for photodynamic therapy, in human colon tumoural cells: a liquid chromatography and MALDI-TOF mass spectrometry analysis.
Laville I; Pigaglio S; Blais JC; Loock B; Maillard P; Grierson DS; Blais J
Bioorg Med Chem; 2004 Jul; 12(13):3673-82. PubMed ID: 15186852
[TBL] [Abstract][Full Text] [Related]
9. Photodynamic efficiency of diethylene glycol-linked glycoconjugated porphyrins in human retinoblastoma cells.
Laville I; Pigaglio S; Blais JC; Doz F; Loock B; Maillard P; Grierson DS; Blais J
J Med Chem; 2006 Apr; 49(8):2558-67. PubMed ID: 16610799
[TBL] [Abstract][Full Text] [Related]
10. Neuropilin-1 suppresses tumorigenic properties in a human pancreatic adenocarcinoma cell line lacking neuropilin-1 coreceptors.
Gray MJ; Wey JS; Belcheva A; McCarty MF; Trevino JG; Evans DB; Ellis LM; Gallick GE
Cancer Res; 2005 May; 65(9):3664-70. PubMed ID: 15867361
[TBL] [Abstract][Full Text] [Related]
11. Interest of RGD-containing linear or cyclic peptide targeted tetraphenylchlorin as novel photosensitizers for selective photodynamic activity.
Frochot C; Di Stasio B; Vanderesse R; Belgy MJ; Dodeller M; Guillemin F; Viriot ML; Barberi-Heyob M
Bioorg Chem; 2007 Jun; 35(3):205-20. PubMed ID: 17223161
[TBL] [Abstract][Full Text] [Related]
12. Functionalized silica-based nanoparticles for photodynamic therapy.
Couleaud P; Bechet D; Vanderesse R; Barberi-Heyob M; Faure AC; Roux S; Tillement O; Porhel S; Guillemin F; Frochot C
Nanomedicine (Lond); 2011 Aug; 6(6):995-1009. PubMed ID: 21726134
[TBL] [Abstract][Full Text] [Related]
13. Antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy can be enhanced by the use of a low dose of photofrin in human tumor xenografts.
Peng Q; Warloe T; Moan J; Godal A; Apricena F; Giercksky KE; Nesland JM
Cancer Res; 2001 Aug; 61(15):5824-32. PubMed ID: 11479222
[TBL] [Abstract][Full Text] [Related]
14. Nuclear estrogen receptor targeted photodynamic therapy: selective uptake and killing of MCF-7 breast cancer cells by a C17alpha-alkynylestradiol-porphyrin conjugate.
Swamy N; Purohit A; Fernandez-Gacio A; Jones GB; Ray R
J Cell Biochem; 2006 Oct; 99(3):966-77. PubMed ID: 16741968
[TBL] [Abstract][Full Text] [Related]
15. Neuropilin-1 targeting photosensitization-induced early stages of thrombosis via tissue factor release.
Bechet D; Tirand L; Faivre B; Plénat F; Bonnet C; Bastogne T; Frochot C; Guillemin F; Barberi-Heyob M
Pharm Res; 2010 Mar; 27(3):468-79. PubMed ID: 20087632
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and biological evaluation of folic acid targeted tetraphenylporphyrin as novel photosensitizers for selective photodynamic therapy.
Schneider R; Schmitt F; Frochot C; Fort Y; Lourette N; Guillemin F; Müller JF; Barberi-Heyob M
Bioorg Med Chem; 2005 Apr; 13(8):2799-808. PubMed ID: 15781391
[TBL] [Abstract][Full Text] [Related]
17. VEGF-A165 induces human aortic smooth muscle cell migration by activating neuropilin-1-VEGFR1-PI3K axis.
Banerjee S; Mehta S; Haque I; Sengupta K; Dhar K; Kambhampati S; Van Veldhuizen PJ; Banerjee SK
Biochemistry; 2008 Mar; 47(11):3345-51. PubMed ID: 18284215
[TBL] [Abstract][Full Text] [Related]
18. Response surface methodology: an extensive potential to optimize in vivo photodynamic therapy conditions.
Tirand L; Bastogne T; Bechet D; Linder M; Thomas N; Frochot C; Guillemin F; Barberi-Heyob M
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):244-52. PubMed ID: 19604651
[TBL] [Abstract][Full Text] [Related]
19. Multiepitope HER2 targeting enhances photoimmunotherapy of HER2-overexpressing cancer cells with pyropheophorbide-a immunoconjugates.
Savellano MD; Pogue BW; Hoopes PJ; Vitetta ES; Paulsen KD
Cancer Res; 2005 Jul; 65(14):6371-9. PubMed ID: 16024640
[TBL] [Abstract][Full Text] [Related]
20. Lentivirus-mediated small interfering RNA targeting VEGF-C inhibited tumor lymphangiogenesis and growth in breast carcinoma.
Guo B; Zhang Y; Luo G; Li L; Zhang J
Anat Rec (Hoboken); 2009 May; 292(5):633-9. PubMed ID: 19382240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]